CIPO Patents = 2

EPO Patents = 3

Forward Citations = 17

Loading Chart...

4 inventors (with patents filed for the assignee):

Matthew F Heil (4 out of 22 patents)

James J Fallon (4 out of 89 patents)

Joan M Fallon (4 out of 66 patents)

4. Stephen J Weiss (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11357835 - Compositions and methods for the treatment or the prevention ofinfections and for the eradication or reduction ofsurfaces (2022-06-14),

2. 10776453 - Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain (2020-09-15),

3. 10736946 - Compositions and methods for treatment or prevention ofinfections and for the eradication or reduction ofon surfaces (2020-08-11),

4. 9895427 - [object Object] (2018-02-20),

Company Overview

Galenagen, LLC is a biotechnology company focused on developing innovative therapeutics for rare genetic diseases. With a mission to improve patients' lives through cutting-edge research and development, Galenagen is dedicated to bringing novel treatments to market. By leveraging advanced technologies and partnerships, the company strives to address unmet medical needs and make a significant impact in the field of rare diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#5 in Rye Brook, NY

#3,680 in New York

#60,641 in US

Rye Brook, NY, United States of America

Galenagen, LLC

Forward Citations = 17

4 inventors:

Matthew F Heil (4 out of 22 patents)

James J Fallon (4 out of 89 patents)

Joan M Fallon (4 out of 66 patents)

4. Stephen J Weiss (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galenagen, LLC. Retrieved from https://idiyas.com/company/galenagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]